chrisvoncsefalvay/vaers-outcomes huggingface dataset:
DRY HEAVES; DIZZINESS; NOT SLEEPING; THROWING UP/NOT ABLE TO KEEP FLUID/BILE COMING UP; NAUSEA; DEHYDRATION; This spontaneous report received from a consumer concerned a 63 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978) dose was not reported, administered on 2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced dehydration. On 31-MAR-2021, the subject experienced dry heaves. On 31-MAR-2021, the subject experienced dizziness. On 31-MAR-2021, the subject experienced not sleeping. On 31-MAR-2021, the subject experienced throwing up/not able to keep fluid/bile coming up. On 31-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from dry heaves, nausea, dizziness, not sleeping, and throwing up/not able to keep fluid/bile coming up, and the outcome of dehydration was not reported. This report was non-serious.
Appx 4 PM pt was given vaccine and about 20 minutes later facial flushing, blotchy, rapid heartbeat/lightheaded. Dr escorted pt to exam room administered 50 mg Diphenhydramine IM. Vitals were taken pre and post vaccine. Pt fully recovered and returned to her work post at front desk.
Syncope followed by seizure or seizure like activity. She was in the car with me on the way home.
Rt arm biceps and tricep-deltoid area. Red, swollen, warm to touch. Advil-Ice, Clarinex 5 mg QD.
Patient believes the Shingrix vaccine has caused her to not be able to raise her arm above her LEFT shoulder.
8/14/07 Office visit; patient presents with urticarial hive-like rash to torso and all extremities; rash began 08/12/07. No fever began Z-Pak.  8/16/07 Rash continues without fever. Z Pak changed to Omnicef. 8/21/07 Rash beginning to resolve; right hand sore with subcutaneous blisters; low grade fever for approximately 2 days and high liver enzymes.
pink area at injection site; injection site hot; injection site achy; more sleep; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (pink area at injection site), VACCINATION SITE WARMTH (injection site hot), VACCINATION SITE PAIN (injection site achy) and HYPERSOMNIA (more sleep) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (pink area at injection site), VACCINATION SITE WARMTH (injection site hot), VACCINATION SITE PAIN (injection site achy) and HYPERSOMNIA (more sleep). At the time of the report, VACCINATION SITE ERYTHEMA (pink area at injection site), VACCINATION SITE WARMTH (injection site hot), VACCINATION SITE PAIN (injection site achy) and HYPERSOMNIA (more sleep) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.  Concomitant medication was not provided.
2 days after receiving vaccine in left deltoid developed moderate pain to left arm and unable to lift arm up all the way, restricted ROM left shoulder
Received the first SHINGRIX vaccine on 7/3/2018. Broke out with Shingles on 7/6/2018. Verified by Dr. on 7/6/2018. As of 8/2/2018, still have Shingles.
High temperture the next 24 hours. Reached a maximum of 101.2F. Was better the next day.
My upper arm has been painful ever since I got the injection. Can barely lift anything heavy.  Interferes with my sleep since I cannot place weight on my arm.  Cannot lift my arm w/o pain.  Can only get my arm over my head by using my left arm to lift it.  Shame on our government for approving something like this and not caring at all how it could horribly affect people's lives.  I have had a flu shot for countless years and have NEVER experienced something like this.  I do not think I will ever regain normal use of my arm.  It has been 2 months now.
Information has been received from a physician concerning a female patient who on approximately 16 Nov 2006 was vaccinated with a 0.5ml IM dose of HPV vaccine. Two days later dosage, on approximately 18 Nov 2006 the patient developed a rash at  injection site. The patient sought unspecified medical attention. Additional information has been requested. This is in follow-up to report(s) previously submitted on 12/14/2006. The patient was told to take BENADRYL and to make appointment. The patient never kept appointment and the office is "unable to contact her".
chills, prickling skin (like the flu), intense body tremors, ligth nausea
difficulty breathing; face was flushed; heart rate went up; Wheezing; This is a spontaneous report from a contactable consumer. A 57-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left, at the age of 57 years, on 26Apr2021 (Batch/Lot Number: EW0170) as 1ST DOSE, SINGLE for covid-19 immunisation. Medical history included autoimmune thyroiditis, allergies, hay fever, allergies to grasses, cheese and weeds; all from an unknown date and unknown if ongoing. Concomitant medication included levothyroxine sodium (LEVOTHYROXIN) taken for autoimmune thyroiditis, start and stop date were not reported and an unspecified Antihistamine. The patient stated that 45 minutes later (26Apr2021) he stated that his face was flushed, his heart was beating fast, he was wheezing and had difficulty breathing but, not severe. He states that these conditions were not serious enough to seek medical attention and reports that they were gone by the end of the next day. The patient reported 5 hours after shot at his symptoms were at about 50 percent of what they were, By the next morning, they were down to about 10 percent and by the end of the day, on 27Apr2021, they were gone. The patient would like to know if this will keep him from getting his second dose of the vaccine. The patient underwent lab tests and procedures which included heart rate: increase on 26Apr2021. The outcome of the events was recovered on 27Apr2021.
On 10/14/16, 51 yo F presented to clinic for nurse only visit for second hepatitis B vaccination. Pt received first vaccination on 09/14/16 without incident. On 10/14 at 1019, pt received hepatitis B vaccine 0.5 mL in right deltoid (NDC: 58160-821-43, Lot #JT379, Exp: 3/10/2019). On 10/16, pt developed blistering and pruritic rash all over her body. After self-treatment with diphenhydramine 50 mg at 1000 and 25 mg at 1500 failed to provide relief, pt presented to urgent care. Pt denied any throat swelling, but did report a mild sore throat sensation and epigastric discomfort. Pt further reported numerous episodes of spontaneous angioedema and urticaria in the past. Pt was referred to ED and report was called in advance of her arrival. Pt prescribed prednisone and was to follow up with her dermatologist. Dermatologist diagnosed mild Stevens-Johnson syndrome and prescribed higher dose of prednisone which pt was taking as directed. On 10/24, pt returned to clinic and exam found symptom improvement with diminished rash and no further skin peeling. Pt continues to be followed by dermatologist. On 10/20, pt's allergy profile was updated to include Hepatitis B Virus Vaccine (rxn: Hives).
8:40 vax given 10AM mild urticaria by report;12noon severe urticaria, w/eruption of small hives on neck-pt took DPH;1PM sx advanced to large hives covering face, neck, head, chest & trunk;on site clinic administered DPH;
Pt was developing normally, still speaking at 20 months. By 24 months, was not speaking at all. Has been dx'd as autistic.
pt. received 2 of the liquid (adjuvant) portion of Arexvy only; pt. received 2 of the liquid (adjuvant) portion of Arexvy only; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number F3Z39, expiry date 25-APR-2026) for prophylaxis.   On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced inappropriate preparation of medication (Verbatim: pt. received 2 of the liquid (adjuvant) portion of Arexvy only) and inappropriate dose of vaccine administered (Verbatim: pt. received 2 of the liquid (adjuvant) portion of Arexvy only). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 16-OCT-2023 The reporter reported that patient received 2 of the liquid (adjuvant) portion of Arexvy only, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. No reactions were reported. The reporter consented to follow up via email.
Low grade fever; Myalgia, Multiple Join pain; Gait impairment. Headache
we were tested positive for corona; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (we were tested positive for corona) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced COVID-19 (we were tested positive for corona). At the time of the report, COVID-19 (we were tested positive for corona) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive. On 04-May-2021, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-102947 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-102947:Husband Case
My biggest issue is the ear ache that I'm still having. That was felt the very next day after my booster which was 9/21. Ear ache caught my attention & it's ringing because it's something I've never had. They gave me some medicine for it that I have to take 3 times a day. Neomycin Neo/Poly/HC 1% OTICSOL Blue 3 drops 3 times daily. I had a virtual telehealth call on 9/21/2021 and was prescribed this medication. I don't know for sure if it's associated with the vaccine or not. It could be simply a coincidence. Dr ordered a MRA/CAT scan for side of head, but have not been scheduled for those appointments yet.
This spontaneous report as received from a nurse refers to a patient of unknown demographics. No concurrent conditions or medical history were provided. On 13-JAN-2015 (reported as "yesterday"), the patient was vaccinated with an expired dose of ZOSTAVAX injection (lot # J011882 with expiry date: 04-JAN-2015; strength, dose and route of administration unspecified). No concomitant medications were reported. No adverse effect was reported. Additional information has been requested.
Fever, chills, body aches, headache that lasted for about 24 hours. I?ve felt weak and fatigue for a week since the shot.
Headache (like the previous 3 shots) and tinnitus.  Really really bad tinnitus. So bad it woke me up from a sound sleep.  My ears are still ringing almost 3 weeks later. It really sucks and I will not be getting another vaccine unless this goes away. Not worth it because this ringing is miserable.  Had no idea this was even possible until I googled side effects and saw other people have had the same thing happen. i know the CDC doesn't recognize it as a side effect but I am convinced it was.
THIS MAY BE UNRELATED.  However, a 7/21/21 CT Scan revealed multiple cavitary lesions in both lungs with the upper dome predominance with numerous micronodules throughout both lungs.
My right armpit has a lump about 2 inches long, 1 inche width, swollen and very uncomfortable.   Below my neck has sharp pain.  This is my 2nd Pfizer Dose.
Difficulty breathing (for 4 days immediately following vaccination), wheezing cough, increased irritability,low grade fever (100.2) for two days, red - swollen shot site & bruising; called doctor's office & made appointment for patient -- prescribed Xopenex 1.25 mg/3 ml for wheezing cough (persisted until 10-25-06).
Adult dose administered to 17 y/o (pt weights 164.5 lbs, 71/5 inches tall).
TINGLING IN THE HANDS AND FEET LIKE A NEUROPATHY; This spontaneous report received from a consumer concerned a patient of unspecified age, sex, race and ethnicity The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) 1 total, dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  The consumer reported that on an unspecified date, the patient experienced tingling in the hands and feet like a neuropathy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of tingling in the hands and feet like a neuropathy was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211058394- Covid-19 vaccine ad26.cov2.s-tingling in the hands and feet like a neuropathy. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Rash; palpitations; spasms in diaphragm lasting 2 days.
14:35 erythema over upper chest 2cm wheal at injection site. Benadryl 12.5/5ml 1 1/2 tsp given PO.
FLARE OF PLAQUE PSORIASIS SPOT ON SIDE OF LEG/PSORIASIS FLARE-UP; HIVES WITH MODERNA INJECTION with HUMIRA (ADALIMUMAB); LIPS SWOLE UP WITH MODERNA INJECTION; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (LIPS SWOLE UP WITH MODERNA INJECTION), PSORIASIS (FLARE OF PLAQUE PSORIASIS SPOT ON SIDE OF LEG/PSORIASIS FLARE-UP) and URTICARIA (HIVES WITH MODERNA INJECTION with HUMIRA (ADALIMUMAB)) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Plaque psoriasis.    No Medical History information was reported.   In 2020, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) UNK Citrate free. In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced LIP SWELLING (LIPS SWOLE UP WITH MODERNA INJECTION). On an unknown date, the patient experienced PSORIASIS (FLARE OF PLAQUE PSORIASIS SPOT ON SIDE OF LEG/PSORIASIS FLARE-UP) and URTICARIA (HIVES WITH MODERNA INJECTION with HUMIRA (ADALIMUMAB)). At the time of the report, LIP SWELLING (LIPS SWOLE UP WITH MODERNA INJECTION) and URTICARIA (HIVES WITH MODERNA INJECTION with HUMIRA (ADALIMUMAB)) had not resolved and PSORIASIS (FLARE OF PLAQUE PSORIASIS SPOT ON SIDE OF LEG/PSORIASIS FLARE-UP) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products were reported.  On an unknown date, the patient experienced flare of plaque psoriasis spot on side of leg/psoriasis flare-up. In 2021, the patient experienced lips swole up with moderna injection and hives with moderna injection. on an unknown date, flare of plaque psoriasis spot on side of leg/psoriasis flare-up resolved. Covid-19 vaccine was also considered suspect. It was unknown if patient was enrolled in a covid-19 vaccine trial. On Apr 2021, patient received 1st dose covid-19 vaccine manufactured by moderna, lot number unknown, expiration date unknown.  Causality for humira (adalimumab) The reporter's causality for the event(s) of lips swole up with moderna injection and hives with moderna injection was not provided. The reporter's causality for the event(s) of flare of plaque psoriasis spot on side of leg/psoriasis flare-up with humira (adalimumab) was a reasonable possibility.  No treatment information was reported by the reporter.  This case was identified as part of a retrospective clean-up activity where certain emails received in the moderna mailbox were missed to be booked-in.
I contracted COVID-19 on 12/21/22 with symptoms of sore throat, headache, nausea, cough, joint pain, grogginess, and fatigue. I was prescribed Paxlovid on 12/23/22. My symptoms have begun to resolve today, which is day 7 of illness, but have not fully resolved. The joint pain worsened on day 6 and 7. I am not recovered as of today day 7 of illness.
Rash on right arm near injection site.  Very red, sore, itchy.  Started 8 days after injection; lasted 15+ days.   Headache, muscle aches and all over "blah" feeling" same day as rash occurred.  Headache, et. al only lasted one day.
Angioedema, UrticariaPruritus, Diarrhea, HYPERtension, Tachycardia, lips tingling Narrative:  Experienced lips tingling, tachycardia (130s), hypertension ( 180/107), and hives on chest approximately 15 minutes after receiving first dose of Moderna vaccine. Administered epinephrine ( dose not listed) and taken out by the squad.  Other Relevant History:
After 72 hrs extreme sore throat/ fever as high as 102.8 , muscle aches , chills and sweating still continuing after 3 days . Called on call doctor and she put me on zpac antibiotics 7pm Feb 6 . With Tylenol and ibuprofen able to get temperature down to 100.1 but goes back up in evening, 102 temp . I feel a little better this morning, temp . 99.8 , still extreme sour throat. On call doctor told me if systems get worse to go to immediate care
Immunizations given 9/10/05. On 9/11/05 at about 8 PM, child with SOB, stridor, retractions; seen in ER and given breathing treatment. Breathing OK but flat red rash all over. Rx with steroid shots, PO Prednisolone and Zyrtec. Fine when seen 9/12/05. To talk to allergist 9/13/05. Medical records state anaphylaxis reaction. msv
Period came 7 days early; I had PMS symptoms much worse than I usually get; Bloating; Overly emotional; Terrible cramps/ soreness; Terrible cramps/ soreness; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 07Apr2021 at 18:00 (at the age of 32-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. On an unknown date in Aug2020, the patient underwent COVID-19 test via nasal swab and the result was negative. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN) 50mg, melatonin (MANUFACTURER UNKNOWN) 5mg and vitamin D NOS (MANUFACTURER UNKNOWN); all for unknown indications from an unknown date and unknown if ongoing. On 16Apr2021, the patient's period came 7 days early. The week prior to that, the patient experienced premenstrual syndrome (PMS) symptoms much worse than she usually got: overly emotional, bloating, terrible cramps and soreness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events period came 7 days early, PMS symptoms much worse than she usually got: overly emotional, bloating, terrible cramps, soreness was resolved on an unspecified date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Severe pain and joint swelling, rash covering back, chest, arms, scalp, and neck
I began to feel like I had a severe case of allergies. My nose was running, eyes were running, post nasal drip and I had a sore throat. I took an at home COVID 19 test that came back inclusive. I went to the local clinic on 09/06/2022 and they confirmed I was positive. They decided not to give any anti-viral medications due to my high blood pressure. Instead I picked up their recommendation of CORICIDIN cold and cough medicine.
This spontaneous report as received from a nurse refers to a 44 year old patient. Medical history and concurrent conditions were not reported. On 27-FEB-2014, the patient was vaccinated with PNEUMOVAX 23 lot #J005067; expiration date: 17-JAN-2015 (dose, strength and route were not reported). Secondary and concomitant therapies were not reported. Nurse called and stated that improperly stored PNEUMOVAX 23 was administered to patient. No adverse effects reported. On 13-JAN-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 2 hours (2 pm - 4 pm) the temperature recorded was 50 degrees F. On 18-JAN-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 2 hours (2 pm - 4 pm) the temperature recorded was 49.1 degrees F. On 10-FEB-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 6 hours (12 pm - 6 pm) the temperature recorded was 51.8 degrees F. On 16-FEB-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 5 hours (12 pm - 5 pm) the temperature recorded was 51.8 degrees F. On 22-FEB-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 4 hours (2 pm - 6 pm) the temperature recorded was 52.7 degrees F. On 09-MAR-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 2 hours (12 pm - 10 pm) the temperature recorded was 55.4 degrees F. On 15-MAR-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 6 hours (8 am - 2 pm) the temperature recorded was 50 degrees F. On 16-MAR-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 20 hours (2 am - 10 pm) the temperature recorded was 64.4 degrees F. On 17-MAR-2014, PNEUMOVAX 23 the temperature reading on the morning was 64.8 degrees F. The total of hours stored outside of recommended temperatures was 55 hours. This is one of several reports from the same reporter. Additional information has been requested.
Gave 3 individuals expired vaccination; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a hospital service technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Gave 3 individuals expired vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C2A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Gave 3 individuals expired vaccination). On 23-May-2021, EXPIRED PRODUCT ADMINISTERED (Gave 3 individuals expired vaccination) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was provided. pharmacist accidently gave and expired vaccine to 3 individuals and the  Pharmacist asked about the stability of the one day expired dose and if a thrid vaccination is required.
Injection site pain; tiredness; headache; chills; fever; nausea; feeling unwell
PATIENT DESCRIBES HAVING CHILLS, HEART PALPITATIONS, HEADACHE, STOMACH ACHE, TIRED, COULD NOT SLEEP, LOW GRADE FEVER LASTED ABOUT 2 DAYS.